Determination of Impurities in New Promising Antioxidants Bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulfide and Dodecyl(3,5-dimethyl-4-hydroxybenzyl)sulfide

Introduction. Dodecyl(3,5-dimethyl-4-hydroxybenzyl)sulfide (T1) and bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulfide (T2) are the collaborative development of Novosibirsk State Pedagogical University and Novosibirsk Research Institute of Antioxidants. It was revealed in several experiments a...

詳細記述

書誌詳細

出版年:	Разработка и регистрация лекарственных средств
主要な著者:	T. G. Shinko, S. V. Terentyeva, S. Ye. Yagunov, N. V. Kandalintseva, O. I. Prosenko, Ye. A. Ivanovskaya, P. I. Pinko
フォーマット:	論文
言語:	ロシア語
出版事項:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-02-01
主題:	impurities dodecyl(3,5-dimethyl-4-hydroxybenzyl)sulfide bis-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]sulfide hplc validation standardization
オンライン･アクセス:	https://www.pharmjournal.ru/jour/article/view/1168